Preterm Labor

Key Points

• Preterm labor is regular uterine contractions with cervical change from 20 weeks to 36 weeks and 6 days of gestation.
• Preterm birth is a major driver of infant mortality and long-term neurodevelopmental disability.
• Tocolysis is used short term to create time for antenatal corticosteroids and fetal benefit, not to prevent birth indefinitely.
• Medication selection depends on gestational age and maternal-fetal contraindications.
• Continuous maternal-fetal monitoring and rapid escalation for progression are core RN priorities.

Pathophysiology

Preterm labor results from premature activation of uterine contraction pathways and cervical remodeling before term. Triggers include infection/inflammation, uterine overdistention (for example multiple gestation or polyhydramnios), cervical insufficiency, uterine structural abnormalities, fetal anomalies, and social-environmental risk burden.

If untreated progression occurs, preterm delivery exposes the newborn to respiratory, neurologic, metabolic, and infectious vulnerability related to organ immaturity.

Classification

• Diagnostic window: Regular contractions with cervical change from 20 weeks to less than 37 weeks.
• PPROM-associated pathway: Rupture of membranes before 37 completed weeks and before spontaneous labor, often interacting with infection and social-risk burden.
• Very preterm management context: Less than 32 weeks, where short-term delay for fetal neuroprotection/lung maturation is high priority.
• Early-late preterm management context: 32 to 34 weeks, where risk-benefit of tocolysis remains individualized.
• Near-term context: More than 34 weeks, where routine tocolysis is often not justified because medication risk may exceed benefit.

Nursing Assessment

NCLEX Focus

Differentiate true preterm labor progression from isolated contractions by tracking cervical change plus contraction pattern and fetal status trends.

• Assess contraction frequency, duration, and intensity with concurrent cervical-change findings.
• Assess maternal vital signs, pain, hydration status, infection cues, and psychosocial stressors.
• Assess fetal heart rate patterns and uterine activity continuously when hospitalized.
• Assess risk factors: prior preterm birth, cervical insufficiency, uterine anomalies, infection, multiple gestation, polyhydramnios, substance use, IPV, low social support, and high-exposure work/standing burden.
• Include PPROM-linked contributors in risk review (for example smoking, low socioeconomic stressors, gestational hypertension, and diabetes).
• Expand risk review to include age extremes, IVF/assisted-reproduction pregnancy, short interpregnancy interval (especially less than about 6 months), and environmental pollutant exposure.
• Include additional associated factors such as threatened early-pregnancy bleeding, fetal anomalies, and periodontal disease.
• Assess medication contraindications before tocolytic selection (cardiac disease, hypotension, diabetes, thrombocytopenia, renal dysfunction, gestational age limits).
• In suspected pathways, interpret fetal fibronectin and cervical-length findings together: a negative fetal fibronectin strongly lowers short-term delivery risk, while cervical length below about 25 mm supports risk but is not standalone diagnostic proof.

Nursing Interventions

• Admit for close maternal-fetal monitoring when true preterm labor is diagnosed.
• Coordinate short-term tocolysis to enable antenatal corticosteroid window when indicated.
• Support gestational-age medication strategy:
• For less than 32 weeks, indomethacin plus corticosteroids for about 48 hours is common; add nifedipine if progression continues.
• For 32 to 34 weeks, nifedipine plus corticosteroids is common; terbutaline may be added in selected progression contexts.
• Avoid indomethacin after 32 weeks because of fetal ductus arteriosus-closure risk.
• Avoid routine tocolytics after 34 weeks when expected fetal benefit is low relative to drug risk.
• Use terbutaline only as short-duration rescue tocolysis (generally no more than 48 to 72 hours) and hold/escalate for maternal pulse above about 120 bpm.
• Administer corticosteroids (for example betamethasone or dexamethasone) when delivery within 7 days is anticipated in eligible gestational windows.
• Use common ACS window reference for threatened preterm birth at about 22 weeks through 33 weeks and 6 days, adjusted to current institutional protocol.
• Encourage hydration, rest, and supportive positioning, but avoid strict prolonged bed rest because thrombosis risk increases.
• Provide focused teaching on medication purpose/adverse effects and immediate return precautions for worsening contractions, bleeding, fluid leakage, fever, or decreased fetal movement.

Progression and Neonatal Risk

Delayed response to progressive preterm labor can rapidly increase risk of preterm birth with severe neonatal complications.

Pharmacology

Drug Class	Examples	Key Nursing Considerations
tocolytics	Indomethacin, nifedipine, terbutaline context	Use short term by gestational-age protocol; monitor maternal hemodynamics and fetal effects.
magnesium-sulfate	Select short-term labor-delay/neuroprotection contexts	Monitor reflexes, respirations, urine output, and toxicity cues.
Antenatal corticosteroids	Betamethasone, dexamethasone	Given when preterm birth risk is high to improve fetal pulmonary maturity.

Clinical Judgment Application

Clinical Scenario

A 30-year-old at 30 weeks presents with painful contractions every 4 minutes, cervical change, and increasing anxiety. Fetal tracing is reassuring.

• Recognize Cues: True preterm labor pattern with active contraction-cervical progression.
• Analyze Cues: Immediate risk is progression to very preterm birth without steroid window.
• Prioritize Hypotheses: Delay delivery briefly to improve fetal outcomes while maintaining maternal safety.
• Generate Solutions: Initiate tocolysis/corticosteroid protocol, continuous monitoring, and contraindication screening.
• Take Action: Implement medication and surveillance plan with frequent reassessment and escalation readiness.
• Evaluate Outcomes: Contractions decrease enough to complete fetal-maturity intervention and ongoing monitoring plan.

Related Concepts

• tocolytics - Core medication framework for short-term contraction inhibition.
• magnesium-sulfate - Used in selected preterm pathways and requires high-alert monitoring.
• preterm-premature-rupture-of-membranes - Major preterm-labor trigger and shared infection-surveillance pathway.
• preterm-newborn - Preterm birth consequences guide urgency of maternal management.
• conditions-limited-to-pregnancy - Preterm labor is a major pregnancy-specific complication category.
• obstetrical-emergencies - Rapid progression can require emergency intrapartum response.

Self-Check

1. Which findings confirm true preterm labor rather than isolated uterine irritability?
2. Why is tocolysis generally limited to short windows rather than prolonged suppression?
3. Which gestational-age thresholds change medication selection in preterm labor?